บทรายงานและการวิเคราะห์ของฝ่ายบริหาร Management Discussion and Analysis For the Financial Result of Quarter 2 Year 2018 Ended June 30, 2018 Note: This Management Discussion and Analysis (MD&A) was
AGM. As the reference no. (2), the Board of Directors’ Meeting no. 247 of the Company, held on March 13, 2020, with the agreement from the Audit Committee, had adopted the resolution to appoint the
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
) EBITDA and EBITDA margin was THB 977mn and 14.0%, respectively, surging by 578.0% or THB 833mn, largely as a result of the aforementioned reasons above and lower loss on impairment of assets Reported net
from the Nation Multimedia Group PCL. (“Seller”) at a price of Baht 9.645 per share, amounting to Baht 407.50 million. The acquisition of WPS shares will result in the WPS being a subsidiary of the
share at the Ministry of Commerce on June 29, 2020. The 3 Months Operating Result as ended 30 June 2020 Financial Performance for the period ended June 30 (Unit : M ill ion Baht) 2020 2019 Inc. / (Dec
the EXAT to compensate the Company for damages as follows: 1) Damages, together with interest, amounting to Baht 1,048 Million, and default interest under the Second Stage Expressway Agreement on such
2.8% Revenue from finance lease under power purchase agreement 95.3 102.4 104.5 2.1% 9.7% 197.6 206.9 4.7% Cost of sales and services (1,174.0) (1,274.4) (1,191.7) (6.5%) 1.5% (2,323.4) (2,466.2) 6.1
from Q2 to Q3. Domestic CMG sales fell by c.5% YoY as a result of shrinking domestic spending Export CMG sales decreased by c.20% due to the implementation of the preventive measures which strictly
resolution by approving the Company to enter into the lease agreement by leasing on Ratchaphatsadu Land in special economic zone, located in Atsamart sub-district, Mueang Nakorn Phanom district, Nakorn Phanom